Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Beyond that, the head-to-head study against tirzepatide and the REDEFINE 3 cardiovascular trial are both ongoing and expected to deliver readouts through 2026 and 2027
See Batch Specific COA Below) Form: Synthetic Peptide Powder Available in 100 mg vials This product is intended strictly for laboratory research use only
For deeper context on the clinical evidence supporting these mechanisms, the GHK-Cu skin UK clinical evidence and HPLC-verified sources resource compiles peer-reviewed trial data with UK-specific sourcing standards
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key
US$ 24.87
US$ 29.92
US$ 24.98
US$ 23.26
US$ 21.05
US$ 24.44
US$ 29.70
US$ 27.61
